The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 333:1145-1146 October 26, 1995 Number 17
NextNext

Broadening the Growth Hormone Insensitivity Syndrome

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
The development of recombinant-DNA–derived human growth hormone (GH) has made it much easier to treat patients with GH deficiency.1 Unfortunately, establishing a firm diagnosis of this deficiency is frequently difficult, even if detailed records of growth are available and many biochemical tests are performed.2 Although the difficulties can be attributed at least in part to the pulsatile secretion of GH and the vagaries of GH assays, they also reflect the complex relation between GH and the insulin-like growth factor (IGF) axis. To be biologically active, GH must bind to a transmembrane receptor, the receptor must form a dimer, and an . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.